Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$110.31 - $140.45 $1.52 Million - $1.94 Million
-13,795 Reduced 17.31%
65,899 $7.47 Million
Q1 2024

May 03, 2024

SELL
$114.22 - $140.1 $9,708 - $11,908
-85 Reduced 0.11%
79,694 $11.1 Million
Q4 2023

Feb 08, 2024

SELL
$75.49 - $124.16 $27,931 - $45,939
-370 Reduced 0.46%
79,779 $9.9 Million
Q3 2023

Nov 09, 2023

SELL
$86.06 - $137.93 $98,108 - $157,240
-1,140 Reduced 1.4%
80,149 $7.48 Million
Q2 2023

Aug 07, 2023

BUY
$112.47 - $130.98 $81,878 - $95,353
728 Added 0.9%
81,289 $10.4 Million
Q1 2023

May 01, 2023

BUY
$104.0 - $122.92 $2.67 Million - $3.16 Million
25,681 Added 46.79%
80,561 $9.36 Million
Q4 2022

Feb 07, 2023

SELL
$84.98 - $122.67 $56,766 - $81,943
-668 Reduced 1.2%
54,880 $6.22 Million
Q3 2022

Oct 25, 2022

BUY
$76.35 - $94.18 $328,534 - $405,256
4,303 Added 8.4%
55,548 $4.47 Million
Q2 2022

Aug 08, 2022

BUY
$67.99 - $132.89 $2.63 Million - $5.14 Million
38,673 Added 307.61%
51,245 $3.82 Million
Q1 2022

May 06, 2022

SELL
$94.08 - $130.2 $73,100 - $101,165
-777 Reduced 5.82%
12,572 $6.43 Million
Q4 2021

Feb 08, 2022

SELL
$129.87 - $162.82 $207,532 - $260,186
-1,598 Reduced 10.69%
13,349 $7.17 Million
Q3 2021

Oct 28, 2021

SELL
$106.71 - $143.18 $119,408 - $160,218
-1,119 Reduced 6.97%
14,947 $8.17 Million
Q2 2021

Jul 27, 2021

BUY
$80.99 - $107.93 $485 - $647
6 Added 0.04%
16,066 $6.86 Million
Q1 2021

May 03, 2021

SELL
$84.79 - $104.74 $73,767 - $91,123
-870 Reduced 5.14%
16,060 $5.77 Million
Q4 2020

Feb 04, 2021

SELL
$78.0 - $104.5 $50,466 - $67,611
-647 Reduced 3.68%
16,930 $6.26 Million
Q3 2020

Nov 06, 2020

BUY
$95.51 - $112.95 $125,309 - $148,190
1,312 Added 8.07%
17,577 $7.25 Million
Q2 2020

Aug 04, 2020

BUY
$62.68 - $105.34 $1.02 Million - $1.71 Million
16,265 New
16,265 $6.59 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Texas Permanent School Fund Portfolio

Follow Texas Permanent School Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Permanent School Fund, based on Form 13F filings with the SEC.

News

Stay updated on Texas Permanent School Fund with notifications on news.